These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25523182)

  • 1. Effectiveness of angiotensin II receptor antagonists in a cohort of Dutch patients with type 2 diabetes mellitus (ZODIAC-14).
    van Hateren KJ; Landman GW; Groenier KH; Bilo HJ; Kleefstra N
    Can J Diabetes; 2015 Apr; 39(2):157-61. PubMed ID: 25523182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is albuminuria screening and treatment optimal in patients with type 2 diabetes in primary care? Observational data of the GIANTT cohort.
    Hellemons ME; Denig P; de Zeeuw D; Voorham J; Lambers Heerspink HJ
    Nephrol Dial Transplant; 2013 Mar; 28(3):706-15. PubMed ID: 23262433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual variability in response to renin angiotensin aldosterone system inhibition predicts cardiovascular outcome in patients with type 2 diabetes: A primary care cohort study.
    Apperloo EM; Pena MJ; de Zeeuw D; Denig P; Heerspink HJL
    Diabetes Obes Metab; 2018 Jun; 20(6):1377-1383. PubMed ID: 29345404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACEI/ARB underused in patients with type 2 diabetes in Chinese population (CCMR-3B study).
    Xie Q; Hao CM; Ji L; Hu D; Zhu T; Li X; Qin D; Zhang D
    PLoS One; 2015; 10(2):e0116970. PubMed ID: 25675409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes: a post-hoc analysis of The Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) study.
    Makino H; Haneda M; Babazono T; Moriya T; Ito S; Iwamoto Y; Kawamori R; Takeuchi M; Katayama S;
    Hypertens Res; 2008 Apr; 31(4):657-64. PubMed ID: 18633177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the stages of diabetic nephropathy at which angiotensin II receptor blockers most effectively suppress albuminuria.
    Ogawa S; Matsushima M; Mori T; Okamura M; Senda M; Sakamoto T; Nako K; Ito S
    Am J Hypertens; 2013 Sep; 26(9):1064-9. PubMed ID: 23775091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension.
    Sengul AM; Altuntas Y; Kürklü A; Aydin L
    Diabetes Res Clin Pract; 2006 Feb; 71(2):210-9. PubMed ID: 16112244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How well are hypertension and albuminuria treated in type II diabetic patients?
    Boero R; Prodi E; Elia F; Porta L; Martelli S; Ferraro L; Quarello F
    J Hum Hypertens; 2003 Jun; 17(6):413-8. PubMed ID: 12764404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of up-titration of candesartan versus candesartan plus amlodipine on kidney function in type 2 diabetic patients with albuminuria.
    Okura T; Kojima M; Machida H; Sugiyama M; Kato T; Komada T; Miyazaki T; Ninomiya T; Ichikawa T; Nakatani K; Watanabe Y; Dohi Y; Ito M; Kimura G
    J Hum Hypertens; 2012 Apr; 26(4):214-9. PubMed ID: 21412266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The renal protective effect of angiotensin receptor blockers depends on intra-individual response variation in multiple risk markers.
    Schievink B; de Zeeuw D; Parving HH; Rossing P; Lambers Heerspink HJ
    Br J Clin Pharmacol; 2015 Oct; 80(4):678-86. PubMed ID: 25872610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midregional fragment of proadrenomedullin, new-onset albuminuria, and cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-30).
    Landman GW; van Dijk PR; Drion I; van Hateren KJ; Struck J; Groenier KH; Gans RO; Bilo HJ; Bakker SJ; Kleefstra N
    Diabetes Care; 2014; 37(3):839-45. PubMed ID: 24170764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
    Eijkelkamp WB; Zhang Z; Remuzzi G; Parving HH; Cooper ME; Keane WF; Shahinfar S; Gleim GW; Weir MR; Brenner BM; de Zeeuw D
    J Am Soc Nephrol; 2007 May; 18(5):1540-6. PubMed ID: 17409317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum uric acid level is associated with metabolic syndrome and microalbuminuria in Korean patients with type 2 diabetes mellitus.
    Kim ES; Kwon HS; Ahn CW; Lim DJ; Shin JA; Lee SH; Cho JH; Yoon KH; Kang MI; Cha BY; Son HY
    J Diabetes Complications; 2011; 25(5):309-13. PubMed ID: 21130003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telmisartan lowers albuminuria in type 2 diabetic patients treated with angiotensin enzyme inhibitors.
    Mazerska M; Myśliwiec M
    Adv Med Sci; 2009; 54(1):37-40. PubMed ID: 19505872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albuminuria in diabetes mellitus: relation to ambulatory versus office blood pressure and effects of cilazapril.
    Waeber B; Weidmann P; Wohler D; Le Bloch Y
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1220-7. PubMed ID: 8972894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study for evaluation of the efficacy and safety of telmisartan in reducing microalbuminuria in hypertensive patients with type 2 diabetes mellitus.
    Kulkarni RB; Kulkarni BN; Hariharan RS; Naikwadi A; Gawde A; Baliga V; Desai A
    J Indian Med Assoc; 2005 Mar; 103(3):187-91. PubMed ID: 16173297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney-protective effects of azelnidipine versus a diuretic in combination with olmesartan in hypertensive patients with diabetes and albuminuria: a randomized study.
    Kojima M; Okubo S; Mizubayashi R; Isaka N; Machida H; Okamoto S; Hirota H; Takeuchi M; Kato T; Nakatani K; Mizuno O; Miyagawa K; Makino K; Okura T; Dohi Y; Ito M; Kimura G
    Nephrol Dial Transplant; 2013 Jul; 28(7):1802-10. PubMed ID: 23535223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers for the Treatment of Hypertension in Adults With Type 2 Diabetes: Why We Favour Angiotensin Receptor Blockers.
    Mavrakanas TA; Lipman ML
    Can J Diabetes; 2018 Apr; 42(2):118-123. PubMed ID: 29602404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria.
    Abe M; Okada K; Maruyama N; Matsumoto S; Maruyama T; Fujita T; Matsumoto K; Soma M
    Hypertens Res; 2011 Feb; 34(2):268-73. PubMed ID: 21124330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Titration of telmisartan, but not addition of amlodipine, reduces urine albumin in diabetic patients treated with telmisartan-diuretic.
    Kojima M; Ohashi M; Dohi Y; Kimura G
    J Hypertens; 2013 Jan; 31(1):186-91. PubMed ID: 23047595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.